SynBiotic SE
SynBiotic SENuWays RecommendationRecommendation
Buy
Price Target
€12.40
Upside
104.62%
Chart
- 1M
- 3M
- 6M
- YTD
- 1Y
- 3Y
€6.06
€0.14 (2.36%)
Realtime-Data from 04.10.2024 15:43:02
SynBiotic is a Buy-and-Build operator in the European industrial hemp, cannabis and cannabinoid market with an objective to establish a fully integrated platform-company with activities across the entire value chain from cultivation to production and retail.
Ticker
SBX GY
Market Cap
€33.93 M
Enterprise Value
€37.01 M
26 week avg vol.
13500
Primar Exchange
Xetra
IPO
2019
Sector
Health Care & Pharma
Headquarters
München, DE
Employees
55
Incorporated
2015
CEO
Daniel Kruse
Website
CEO
7.62%
Other institutional investors
47.00%
Free Float
45.38%
20.09.2024
Annual General Meeting
30.09.2024
Publication half yearly financial report
KPIs in EUR
| KPI | 2023 | 2024e | 2025e |
|---|---|---|---|
| Sales | 3.86 M | 14.96 M | 23.04 M |
| EBITDA | (7.19 M) | (1.09 M) | 1.49 M |
| EBIT | (11.75 M) | (2.20 M) | 412.35 K |
| EPS | (2.12) | (0.31) | 0.02 |
| FCF | (2.94 M) | (4.14 M) | 860.32 K |
Valuation
| KPI | 2023 | 2024e | 2025e |
|---|---|---|---|
| EV / Sales | 9.58x | 2.44x | 1.54x |
| EV / EBITDA | (5.14x) | (33.51x) | 23.86x |
| EV / EBIT | (3.15x) | (16.55x) | 86.28x |
| Price / Earnings | (2.85x) | (19.36x) | 361.68x |
| EV / FCF | (12.57x) | (8.82x) | 41.35x |
Downloads
Latest Research
Initiation